Home/Filings/4/0001628280-21-000147
4//SEC Filing

Cadavid Diego 4

Accession 0001628280-21-000147

CIK 0001501697other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 8:23 AM ET

Size

5.6 KB

Accession

0001628280-21-000147

Insider Transaction Report

Form 4
Period: 2020-12-31
Cadavid Diego
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-12-31$6.43/sh+121,500$781,245121,500 total
    Exercise: $6.43Exp: 2030-12-31Common Stock (121,500 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option shall vest on December 31, 2021, with the remainder vesting in equal installments of 2.0833% of the shares subject to the option each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date.

Issuer

X4 Pharmaceuticals, Inc

CIK 0001501697

Entity typeother

Related Parties

1
  • filerCIK 0001778713

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 8:23 AM ET
Size
5.6 KB